7 Recruiting Myelodysplastic Syndromes Phase 3 Clinical Trials
Active phase 3 studies for myelodysplastic syndromes enrolling across the USA. Verify eligibility and contact site coordinators.
All Myelodysplastic Syndromes studiesPhase 3 Studies for Myelodysplastic Syndromes
🔵 Active, Not Recruiting Phase3
ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
📍 Local Institution - 0070 — Clovis, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 / Phase3
Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
📍 UAB Comprehensive Cancer Center — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 / Phase3
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)
📍 Local Institution - 0137 — Miami, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants
📍 Local Institution - 0051 — Los Alamitos, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve
📍 Local Institution - 107 — Berkeley, California
View Study & Checklist ➔ 🟢 Recruiting Phase2 / Phase3
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
📍 Keck School of Medicine of USC — Los Angeles, California
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
📍 City of Hope — Duarte, California
View Study & Checklist ➔